Influence of DPYD*9A, DPYD*6 and GSTP1 ile105val Genetic Polymorphisms on Capecitabine and Oxaliplatin (CAPOX) Associated Toxicities in Colorectal Cancer (CRC) Patients

AIM: CAPOX treatment in CRC patients was reported to cause several dose-limiting toxicities, and are found responsible for treatment interruption or even discontinuation. Therefore there is a critical need for identifying the predictive biomarkers for such toxicities to prevent them. The aim of our...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Asian Pac J Cancer Prev
Asıl Yazarlar: K, Ashok Varma, Jayanthi, M, Dubashi, Biswajit, Shewade, D G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: West Asia Organization for Cancer Prevention 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982684/
https://ncbi.nlm.nih.gov/pubmed/31653159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.3093
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller